OBI Programs/Events

As part two of our three-part Virtual Lunch & Learn series on U.S. drug development, this session will focus on the critical role of FDA interactions in a successful pharmaceutical development strategy. Part 2 will provide a more in-depth understanding of communications with the FDA to facilitate successful product development. We will discuss the different types of interactions […]